KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,401,000 | 0.0% | 153,449 | 0.0% | 0.62% | +3.7% |
Q4 2018 | $1,401,000 | -19.7% | 153,449 | +50.4% | 0.60% | +0.2% |
Q3 2018 | $1,744,000 | +2135.9% | 102,006 | +774.7% | 0.60% | +1516.2% |
Q2 2016 | $78,000 | -25.0% | 11,662 | 0.0% | 0.04% | -26.0% |
Q1 2016 | $104,000 | -32.9% | 11,662 | 0.0% | 0.05% | -32.4% |
Q4 2015 | $155,000 | +26.0% | 11,662 | 0.0% | 0.07% | +19.4% |
Q3 2015 | $123,000 | -61.2% | 11,662 | 0.0% | 0.06% | -56.9% |
Q2 2015 | $317,000 | -11.2% | 11,662 | 0.0% | 0.14% | -11.7% |
Q1 2015 | $357,000 | +149.7% | 11,662 | +205.4% | 0.16% | +143.3% |
Q4 2014 | $143,000 | +7.5% | 3,819 | 0.0% | 0.07% | – |
Q3 2014 | $133,000 | -25.3% | 3,819 | 0.0% | 0.00% | -100.0% |
Q2 2014 | $178,000 | – | 3,819 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |